Reducing the Time to Start Treatment for First Episode Psychosis through Screenings and Clearer Information

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This trial uses a stepped-wedge cluster randomized design to compare two approaches: a systematic screening method (SM) and a systematic screening method enhanced with a communication model (SCM). The goal is to see if SCM helps more patients start specialty services sooner and reduces the duration of untreated psychosis (DUP) in youth and young adults at risk or experiencing first episode psychosis. Participants aged 12–30 are screened in clinical settings, with those who screen positive undergo further assessment and potential rapid referral to Coordinated Specialty Care. The study adapts a Dutch screening approach to a U.S. setting within Mount Sinai Health System, and includes qualitative work to understand barriers and facilitators to timely engagement.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* age 12- 30
* ability to participate in assessments in English or Spanish
* ability to provide informed consent (assent for those under age 18)

Exclusion Criteria:

* previous diagnosis of schizophrenia, schizoaffective disorder, schizophreniform disorder, or delusional disorder.

Where it's running

• Icahn School of Medicine at Mount Sinai
  New York, New York, United States Recruiting

Study contacts

• Principal investigator: Yulia Landa, PsyD, MS — Icahn School of Medicine at Mount Sinai
• Study coordinator: Yulia Landa, PsyD, MS
• Email: yulia.landa@mssm.edu
• Phone: 212-585-4658

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• French Minds: a French, Multimodal Cohort Study of Severe Psychiatric Disorders and Healthy Controls

  This study tests whether people with mood, psychotic, or autism disorders can be grouped into more similar subtypes based on social withdrawal and anhedonia, across ages 15 to 60.

  Recruiting at 10 sites Fondation FondaMental · Besançon and 16 other locations · NCT07881016

• Accelerated Brain Stimulation for Young People at Risk of Psychosis

  This study tests a five-day accelerated brain-stimulation treatment to see if it is safe and tolerable for young people at risk for psychosis and to explore biomarkers that might show whether it works.

  Recruiting Douglas Mental Health University Institute · Verdun, Quebec · NCT07786714

• Recovery-oriented suicide prevention for young people at clinical high risk for psychosis

  This program tests a peer-supported, clinician-led suicide prevention group for young people at clinical high risk for psychosis to see if it helps reduce suicidal thoughts and support recovery.

  Recruiting at 2 sites University of California, San Diego · Los Angeles, California and 1 other locations · NCT07756567

• Enhancing cognitive self-management to improve work and school outcomes in first-episode psychosis

  This pilot study tests whether adding a cognitive self-management program to standard employment and education services helps young adults with first-episode psychosis find and stay in work or school.

  Recruiting at 3 sites Boston University Charles River Campus · Big Spring, Texas and 3 other locations · NCT07749105

• Mindfulness group experiences for young people at high risk for or early in psychosis

  This project tries to understand how group mindfulness sessions feel for French-speaking young people aged 15–30 who are at ultra‑high risk for psychosis or have had a first episode.

  Recruiting at 2 sites Centre Psychothérapique de Nancy · Laxou and 1 other locations · NCT07499934

• Biomarker changes after MT1988 dosing in young people at high risk for psychosis

  This will test whether two doses of MT1988 taken twice daily for 8 weeks change biomarker tests in 17–30-year-olds at high risk for psychosis compared with placebo.

  Recruiting at 15 sites Phase 1/2 Monument Therapeutics Limited · Irvine, California and 14 other locations · NCT07226895

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.